Search results for “Cutaneous lupus” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 136 patents, we discovered top 22 key players by total patent application. Celgene Corp., Rigel Pharmaceuticals, Inc., Genentech, Inc. are dominant in this area. They take 36.76% of the total patent filing.
Celgene Corp.
New Jersey, United States
Patent: 19
Rigel Pharmaceuticals, Inc.
California, United States
Patent: 19
Genentech, Inc.
California, United States
Patent: 12
Jubilant Epipad LLC
United States
Patent: 11
Novartis AG
Basel-Stadt, Switzerland
Patent: 10
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 8
Galapagos NV
Belgium
Patent: 7
Glaxo Group Ltd.
Hounslow, United Kingdom
Patent: 7
Science & Technology Corp.
Virginia, United States
Patent: 6
Jubilant Biosys Ltd.
Karnataka, India
Patent: 5
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Dermavant Sciences GmbH
Basel-Stadt, Switzerland
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 44 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing Jubilant Epipad LLC, Novartis AG, Jubilant Biosys Ltd. take 54.55% of patent filing during this period.
Jubilant Epipad LLC
United States
Patent: 11
Novartis AG
Basel-Stadt, Switzerland
Patent: 10
Jubilant Biosys Ltd.
Karnataka, India
Patent: 3
TransThera Sciences (Nanjing), Inc.
Jiangsu Sheng, China
Patent: 3
Pfizer Inc.
New York, United States
Patent: 3
STARTUP
Dermavant Sciences GmbH
Basel-Stadt, Switzerland
Patent: 2
Landos Biopharma, Inc.
Virginia, United States
Patent: 2
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Bristol Myers Squibb Co.
New York, United States
Patent: 1
LEO Pharma A/S
Hovedstaden, Denmark
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 44 patents in last 5 years, we discover 11 new entrants. Jubilant Epipad LLC, Novartis AG, Pfizer Inc. are the most active new entrants in this area.
Jubilant Epipad LLC
United States
Patent: 11
Novartis AG
Basel-Stadt, Switzerland
Patent: 10
Pfizer Inc.
New York, United States
Patent: 3
TransThera Sciences (Nanjing), Inc.
Jiangsu Sheng, China
Patent: 3
Landos Biopharma, Inc.
Virginia, United States
Patent: 2
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 2
STARTUP
Dermavant Sciences GmbH
Basel-Stadt, Switzerland
Patent: 2
Bristol Myers Squibb Co.
New York, United States
Patent: 1
Nanchang Antisense Bio-Pharmaceutical Co., Ltd.
Jiangxi Sheng, China
Patent: 1
LEO Pharma A/S
Hovedstaden, Denmark
Patent: 1
Research Institutions
Order by:
Innovation Intensity
No data, please try another search term
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: